MedTrace Logo

Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT00805012 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2011-07-26

No results posted yet for this study

Summary

To assess response rate of docetaxel and S-1 combination in metastatic or recurrent head and neck squamous cell carcinoma

Conditions

Interventions

DRUG

docetaxel+CDDP

docetaxel+CDDP

DRUG

docetaxel+S-1

docetaxel+S-1

Sponsors & Collaborators

  • Clinical Research Center for Solid Tumor, Korea

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805012 on ClinicalTrials.gov